Breathment raises €800K pre-seed to revolutionize respiratory care with AI-powered digital therapies

German healthtech startup Breathment has secured €800,000 in pre-seed funding from SCE Freiraum Ventures, Michael Friebe, Meerkat Holding, Claudia Fell, and Alihan Ozbayrak, as the company scales its AI-powered digital therapy platform serving chronic respiratory patients across Europe while transforming traditional physiotherapy access through remote monitoring and personalized treatment protocols.

Breathment addresses the critical gap in respiratory care accessibility by combining healthcare professional expertise with AI. The company's platform enables patients with COPD, asthma, and other chronic respiratory conditions to receive personalized therapy from home while maintaining continuous connection with healthcare providers.

Central to Breathment's approach is their digital therapy ecosystem that integrates AI-driven personalized treatment plans, remote patient monitoring, and healthcare provider workflows. The CE-marked medical device platform delivers flexible, professional care without waiting times, particularly targeting patients who lack access to nearby physiotherapy and outpatient rehabilitation services across Germany and expanding European markets. The company's solution also includes digital COPD therapy, digital asthma therapy, online physiotherapy, and prevention courses, all designed to improve patient quality of life while optimizing healthcare provider efficiency.

Strategic medical advisory support comes from leading specialists including Dr. med. Korkut Avsar (Internal Medicine, Pulmonology), Dr. med. Sarah-Christin Mavi (Internal Medicine, Pulmonology), and Prof. Dr. med. Thomas Loew (Psychiatry, Psychosomatics and Psychotherapy), ensuring clinical excellence and regulatory compliance across European healthcare markets.

The founding team brings complementary expertise across technology development, healthcare operations, and business strategy, with strong connections to Germany's thriving healthtech ecosystem. Their mission emphasizes that technology enhances rather than replaces healthcare professionals, positioning Breathment as a collaborative tool for improved patient outcomes.

With chronic respiratory diseases affecting over 400 million people globally and traditional care models facing capacity constraints, Breathment's AI-powered approach addresses both accessibility and personalization challenges in respiratory healthcare.

Founders: Elçin Can Çavuşoğlu, Yalvaç Top, Baturay Yalvaç

Sources: Crunchbase, Breathment, egirisim